Evidence map›Paper›PMID 41857003›Full record

ArticleTranslational psychiatry2026

Data-driven schizophrenia subtyping via brain atrophy trajectories and functional connectivity.

Daisuke Yoshimaru, Kazuya Ouchi, Shuhei Shibukawa, Masakazu Ozawa, Motoki Hirabayashi, Ami Yuzawa, Tomokazu Tsurugizawa, Kenichi Oishi, Hirotaka James Okano

Abstract read
In one paragraph

Article in Translational psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Daisuke YoshimaruDivision of Regenerative Medicine, The Jikei University School of Medicine, Tokyo, 105-8461, Japan. d.marumaru@gmail.com.ORCID http://orcid.org/0000-0001-8612-4917
Kazuya OuchiNational Institute of Advanced Industrial Science and Technology (AIST), Tsukuba, 305-8565, Japan.
Shuhei ShibukawaDepartment of Radiology, Tokyo Medical University, Tokyo, 160-0023, Japan. shuhei.shibu@gmail.com.
Masakazu OzawaDivision of Regenerative Medicine, The Jikei University School of Medicine, Tokyo, 105-8461, Japan.ORCID http://orcid.org/0000-0003-4659-2462
Motoki HirabayashiDivision of Regenerative Medicine, The Jikei University School of Medicine, Tokyo, 105-8461, Japan.
Ami YuzawaDivision of Regenerative Medicine, The Jikei University School of Medicine, Tokyo, 105-8461, Japan.
Tomokazu TsurugizawaNational Institute of Advanced Industrial Science and Technology (AIST), Tsukuba, 305-8565, Japan.ORCID http://orcid.org/0000-0003-3194-578X
Kenichi OishiDepartment of Radiology, The Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA.ORCID http://orcid.org/0000-0002-1200-8611
Hirotaka James OkanoDivision of Regenerative Medicine, The Jikei University School of Medicine, Tokyo, 105-8461, Japan.ORCID http://orcid.org/0000-0003-4611-7098

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Schizophrenia exhibits substantial clinical and neuroanatomical heterogeneity, yet conventional cross-sectional studies typically analyse patients at different disease stages as homogeneous groups, diluting pathological diversity. We applied the Subtype and Stage Inference (SuStaIn) algorithm to structural MRI data from 85 patients with schizophrenia and 224 healthy controls, integrating this with resting-state functional MRI analysis for the first time. SuStaIn identified two distinct neuroanatomical subtypes: Subtype0 demonstrated anterior-to-posterior progression with early frontal-limbic atrophy and prominent positive symptoms, while Subtype1 exhibited posterior-to-anterior progression originating in subcortical-occipital regions with greater social withdrawal. Disease progression stage correlated with functional connectivity in opposing directions-Subtype0 showed hypoconnectivity (ρ = -0.56) while Subtype1 exhibited hyperconnectivity (ρ = 0.70). These contrasting patterns may explain decades of contradictory functional connectivity findings in schizophrenia literature, as previous studies likely captured different subtypes at various disease stages. Our integrated structure-function approach reveals distinct disease trajectories that could inform subtype-specific therapeutic strategies.

Indexed as

BrainSchizophreniaAdultAtrophyCase-Control StudiesConnectomeDisease ProgressionFemaleHumansMagnetic Resonance ImagingMaleMiddle AgedNeural Pathways

Identifiers

PMID41857003
PMCPMC13043883

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.